sorafenib has been researched along with Co-infection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aleixo, MJ; Fonseca, C; Fonseca, J; Nunes, G; Patita, M; Ramalho, M | 1 |
| Abou-Alfa, GK; Dika, IE; Harding, JJ | 1 |
| Chamalidou, E; Chelis, L; Deftereos, S; Kakolyris, S; Maltezos, E; Ntinos, N; Souftas, V; Xenidis, N | 1 |
1 review(s) available for sorafenib and Co-infection
| Article | Year |
|---|---|
Hepatocellular carcinoma in patients with HIV.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Coinfection; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Liver Transplantation; Mass Screening; Niacinamide; Phenylurea Compounds; Sorafenib | 2017 |
2 other study(ies) available for sorafenib and Co-infection
| Article | Year |
|---|---|
Diffuse advanced hepatocellular carcinoma after HCV eradication in an HIV-infected patient: A unique complete response to sorafenib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Coinfection; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Induction Chemotherapy; Liver Neoplasms; Male; Sorafenib | 2020 |
Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report.
Topics: Aged; Antiretroviral Therapy, Highly Active; Benzenesulfonates; Carcinoma, Hepatocellular; Coinfection; Drug Synergism; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Treatment Outcome | 2011 |